Replies to post #25 on Equity Field Notes from temporal sources

[DanWebzster]

MESO

Reported exceptionally good results in Ph3 study treating steroid refractory GvHD.

Accelerated Approval is possible

Cash runway will only take it thru 2018

It may tap 90mn equity facility until partner is secured.

Seems intent on securing partner rather than diluting.